Candidate vaccine by SII, Oxford varsity to join Ebola trial: WHO
The candidate vaccine developed by the Oxford University and the Serum Institute of India is among the two such vaccines added to the ongoing Ebola clinical trials, according to a World Health Organisation (WHO) statement, making it the first addition of candidate vaccines to the trials specifically targeting the Bundibugyo virus that has caused the current Ebola outbreak in the Democratic…

Read at Hindustan Times(opens in a new tab)
Full coverage
Candidate vaccine by SII, Oxford varsity to join Ebola trial: WHO (opens Hindustan Times in a new tab)
The candidate vaccine developed by the Oxford University and the Serum Institute of India is among the two such vaccines added to the ongoing Ebola clinical trials, according to a World Health Organisation (WHO) statement, making it the first addition of…


